Body fat phenotypes and treatment response to spironolactone in ambulatory patients with heart failure and preserved ejection fraction: a post‐hoc analysis of the Aldo‐DHF trial
2020 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Body fat phenotypes and treatment response to spironolactone in ambulatory patients with heart failure and preserved ejection fraction: a post‐hoc analysis of the Aldo‐DHF trial
Petutschnigg, J.; Ferreira, J. P.; Holzendorf, V.; Trippel, T. D.; Hashemi, D.; Wachter, R. & Herrmann‐Lingen, C. et al. (2020)
European Journal of Heart Failure, 22(3) pp. 559-561. DOI: https://doi.org/10.1002/ejhf.1723
Documents & Media
Details
- Authors
- Petutschnigg, Johannes; Ferreira, João Pedro; Holzendorf, Volker; Trippel, Tobias D.; Hashemi, Djawid; Wachter, Rolf ; Herrmann‐Lingen, Christoph ; Hasenfuß, Gerd ; Zannad, Faiez; Pieske, Burkert ; Edelmann, Frank
- Issue Date
- 2020
- Journal
- European Journal of Heart Failure
- ISSN
- 1388-9842
- eISSN
- 1879-0844
- Language
- English
